TOP TIERMARKET NEWSWIRE
News & sentiment

IDEAYA BIOSCIENCES I (IDYA) — News & AI sentiment

IDEAYA BIOSCIENCES I (IDYA) news roundup. 5 stories in the past week, 13 over 30 days. Average 30-day sentiment is 61.5/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $382K — net selling of $382K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
5
avg sentiment 59.4/100
30d stories
13
avg sentiment 61.5/100
Insider net (90d)
$382K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

IDYA news in the last 24 hours, 7 days, 30 days and 90 days

How much IDYA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowIDYA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days559.4/100IDYA headlines →
Last 30 days1361.5/100IDYA headlines →
Last 90 days2757.8/100IDYA headlines →

Latest stories on IDYA

3d ago
Guggenheim raises Ideaya Biosciences stock price target on DLL3 data
Investing.com Analyst Ratings61 · neutralanalyst
4d ago
4d ago
4d ago
4d ago
Sep 1
Citizens upgrades Ideaya Biosciences stock rating on IDE849 progress
Investing.com Analyst Ratings61 · neutralanalyst
Sep 1
Aug 31
Aug 31
Aug 28
Aug 25
Aug 19
Aug 19
Aug 6
Aug 4
Aug 4
Aug 4
Jul 31
Jul 27
Jul 17
Jul 17
Jun 26
Jun 26
Jun 23
Jun 18
Open IDYA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →